Lau Sin Ting, Lin Zhi-Xiu, Liao Yonghong, Zhao Ming, Cheng Christopher H K, Leung Po Sing
Department of Physiology, The Chinese University of Hong Kong, Shatin, NT, SAR, China.
Cancer Lett. 2009 Aug 18;281(1):42-52. doi: 10.1016/j.canlet.2009.02.017. Epub 2009 Mar 14.
Pancreatic cancer is a malignant disease with extremely high mortality. Our previous work found that Brucea javanica fruit possesses potent anti-pancreatic cancer activity. In the present study, brucein D (BD), a quassinoid found abundantly in B. javanica fruit, was evaluated for its anti-proliferative and apoptogenic actions. BD inhibited the growth of three pancreatic cancer cell lines, i.e., PANC-1, SW1990 and CAPAN-1, but exerted only modest cytotoxicity on non-tumorigenic Hs68 cells. Hoechst 33342 staining and Cell Death Detection ELISA(PLUS) assay revealed that BD-induced DNA fragmentation in PANC-1 cells. Moreover, subG1 phase was observed in the BD-treated cells. Western blot experiments indicated that BD exposure augmented caspase 3, 8, 9 and bak protein levels, while attenuating the expression of bcl-2. Furthermore, BD treatment promoted phosphorylation of p38-MAPK. The selective p38-MAPK inhibitor SB203580 effectively mitigated the BD-induced apoptosis in PANC-1 cells, suggesting that p38-MAPK signaling pathway was involved in the BD-induced apoptosis in pancreatic cancer cells. Taken together, our results provide experimental evidence to support the traditional use of B. javanica fruit in cancer treatment, and render BD a promising chemical candidate for further development into anti-pancreatic cancer agent.
胰腺癌是一种死亡率极高的恶性疾病。我们之前的研究发现鸦胆子果实具有强大的抗胰腺癌活性。在本研究中,对鸦胆子果实中大量存在的苦木素D(BD)的抗增殖和诱导凋亡作用进行了评估。BD抑制了三种胰腺癌细胞系即PANC-1、SW1990和CAPAN-1的生长,但对非致瘤性Hs68细胞仅产生适度的细胞毒性。Hoechst 33342染色和细胞死亡检测ELISA(PLUS)分析显示BD诱导PANC-1细胞中的DNA片段化。此外,在BD处理的细胞中观察到亚G1期。蛋白质印迹实验表明,BD处理增加了半胱天冬酶3、8、9和Bak蛋白水平,同时减弱了bcl-2的表达。此外,BD处理促进了p38丝裂原活化蛋白激酶(p38-MAPK)的磷酸化。选择性p38-MAPK抑制剂SB203580有效减轻了BD诱导的PANC-1细胞凋亡,表明p38-MAPK信号通路参与了BD诱导的胰腺癌细胞凋亡。综上所述,我们的结果提供了实验证据来支持鸦胆子果实在癌症治疗中的传统用途,并使BD成为进一步开发为抗胰腺癌药物的有前景的化学候选物。